New Jersey Sample Contracts

Share Cite Term
Link

Embed (HTML)
BMW Vehicle Lease Trust 2017-2 – FORM OF ASSET REPRESENTATIONS REVIEW AGREEMENT BMW VEHICLE LEASE TRUST 2017-2, as Issuer and BMW FINANCIAL SERVICES NA, LLC, as Servicer (October 19th, 2017)

This ASSET REPRESENTATIONS REVIEW AGREEMENT (this "Agreement"), entered into as of the 25th day of October 2017, by and among BMW VEHICLE LEASE TRUST 2017-2, a Delaware statutory trust (the "Issuer"), BMW FINANCIAL SERVICES NA, LLC, a Delaware limited liability company (the "Servicer"), and CLAYTON FIXED INCOME SERVICES LLC, a Delaware limited liability company (the "Asset Representations Reviewer").

BMW Vehicle Lease Trust 2017-2 – BMW VEHICLE LEASE TRUST 2017-2 1.35000% Asset Backed Notes, Class A-1 1.80% Asset Backed Notes, Class A-2a LIBOR Plus 0.18% Asset Backed Notes, Class A-2b 2.07% Asset Backed Notes, Class A-3 2.19% Asset Backed Notes, Class A-4 U.S. BANK NATIONAL ASSOCIATION, as Indenture Trustee, and BMW VEHICLE LEASE TRUST 2017-2, as Issuer FORM OF INDENTURE Dated as of October 25, 2017 (October 19th, 2017)

This Indenture, dated as of October 25, 2017, is between BMW Vehicle Lease Trust 2017-2, a Delaware statutory trust (the "Issuer"), and U.S. Bank National Association, a national banking association, as indenture trustee (the "Indenture Trustee").

Stitch Fix, Inc. – OFFICE LEASE POST MONTGOMERY CENTER ONE MONTGOMERY TOWER San Francisco, California BASIC LEASE INFORMATION (October 19th, 2017)
Smart Trust 346 – October 19, 2017 (October 19th, 2017)

The Bank of New York Mellon is acting as trustee for the series of Smart Trust set forth above (the "Trust"). We enclosed a list of the Securities to be deposited in the Trust on the date hereof. The prices indicated therein reflect our evaluation of such Securities as of close of business on October 18, 2017, in accordance with the valuation method set forth in the Standard Terms and Conditions of Trust and Trust Agreement. We consent to the reference to The Bank of New York Mellon as the party performing the evaluations of the Trust Securities in the Registration Statement (No. 333-219813) filed with the Securities and Exchange Commission with respect to the registration of the sale of the Trust Units and to the filing of this consent as an exhibit thereto.

BMW Vehicle Lease Trust 2017-2 – BMW AUTO LEASING LLC, as Transferor, and WILMINGTON TRUST, NATIONAL ASSOCIATION, as Owner Trustee FORM OF AMENDED AND RESTATED TRUST AGREEMENT Dated as of October 25, 2017 (October 19th, 2017)

This Amended and Restated Trust Agreement, dated as of October 25, 2017, is between BMW Auto Leasing LLC, a Delaware limited liability company, as transferor (the "Transferor"), and Wilmington Trust, National Association, a national banking association, as trustee (the "Owner Trustee").

SHARE PURCHASE AGREEMENT Among IMPALA PRIVATE HOLDINGS II, LLC SYNCHRONOSS TECHNOLOGIES, INC. And INTRALINKS HOLDINGS, INC. Dated as of October 17, 2017 (October 19th, 2017)

SHARE PURCHASE AGREEMENT, dated as of October 17, 2017 (this Agreement), among IMPALA PRIVATE HOLDINGS II, LLC, a Delaware limited liability company (Purchaser), SYNCHRONOSS TECHNOLOGIES, INC., a Delaware corporation (Seller), and INTRALINKS HOLDINGS, INC., a Delaware corporation and a wholly owned subsidiary of Seller (the Company).

Morgan Stanley Bank of America Merrill Lynch Trust 2017-C34 – Contract (October 19th, 2017)
BMW Vehicle Lease Trust 2017-2 – BMW MANUFACTURING L.P., as Grantor and UTI Beneficiary, and BNY MELLON TRUST OF DELAWARE, Formerly Known as the Bank of New York (Delaware), as Vehicle Trustee FORM OF 2017-2 VEHICLE TRUST SUPPLEMENT Dated as of October 25, 2017 (October 19th, 2017)

the Indenture, as the case may be. Whenever used herein, unless the context otherwise requires, the following words and phrases shall have the following meanings:

Receivable Acquisition And Management Corporatio – FORM OF SUBSCRIPTION AGREEMENT PWRCOR, INC. Investor Subscription Documents a Private Offering to Accredited Investors (October 18th, 2017)

THIS QUESTIONNAIRE IS TO BE COMPLETED AND DELIVERED TO DAVIDOFF HUTCHER & CITRON LLP. PRIOR TO ACCEPTANCE OF THE SUBSCRIPTION BY THE COMPANY, CERTAIN CONDITIONS MUST BE MET.

ASSET PURCHASE AGREEMENT by and Between Pivotal Utility Holdings, Inc. As Seller, and South Jersey Industries, Inc. As Buyer Dated as of October 15, 2017 (October 18th, 2017)

THIS ASSET PURCHASE AGREEMENT ("Agreement") is made and entered into as of October 15, 2017, by and between Pivotal Utility Holdings, Inc., a New Jersey corporation ("Seller"), and South Jersey Industries, Inc., a New Jersey corporation ("Buyer" and together with Seller, the "Parties" and each individually a "Party").

Aspect FuturesAccess LLC – Fifth Amended and Restated Limited Liability Company Operating Agreement (October 18th, 2017)

All determinations of value by the Sponsor shall be final and conclusive as to all Investors, in the absence of manifest error, and the Sponsor shall be absolutely protected in relying upon valuations furnished to the Sponsor by third parties, provided that such reliance is in good faith.

ML Winton FuturesAccess LLC – Sixth Amended and Restated Limited Liability Company Operating Agreement (October 18th, 2017)

All determinations of value by the Sponsor shall be final and conclusive as to all Investors, in the absence of manifest error, and the Sponsor shall be absolutely protected in relying upon valuations furnished to the Sponsor by third parties, provided that such reliance is in good faith.

ACM Research, Inc. – Class a Common Stock Purchase Warrant Acm Research, Inc. (October 18th, 2017)

THIS CLASS A COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, [*] or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [*], 2017 (the Original Issue Date) and, in accordance with FINRA Rule 5110(f)(2)(H)(i), will expire at 5:00 p.m. (New York time) on the [*], 20222 (the Termination Date) but not thereafter, to subscribe for and purchase from ACM Research, Inc. a Delaware corporation (the Company), up to [*]3 shares (as subject to adjustment hereunder, the Warrant Shares) of the Companys Class A common stock, $0.0001 par value per share (Common Stock). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Catalent, Inc. – INDENTURE Dated as of October 18, 2017 Among CATALENT PHARMA SOLUTIONS, INC. The Guarantors Listed Herein and DEUTSCHE BANK TRUST COMPANY AMERICAS as Trustee 4.875% SENIOR NOTES DUE 2026 (October 18th, 2017)

This INDENTURE, dated as of October 18, 2017, is among Catalent Pharma Solutions, Inc. (the Issuer), a Delaware corporation, the Guarantors (as defined herein) listed on the signature pages hereto, and Deutsche Bank Trust Company Americas, a New York banking corporation, as trustee (the Trustee).

Ablynx NV – Amendment (October 17th, 2017)

This amendment (Amendment), executed on July 20, 2015, is an amendment to the RESEARCH COLLABORATION AND EXCLUSIVE LICENSE AGREEMENT with an effective date of January 31, 2014 (Agreement) entered into by and between MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey (Merck) and ABLYNX N.V., a limited liability company organized and existing under the laws of Belgium (Ablynx) registered with the legal entities register under number BE 0475295446 (district of Ghent) and whose registered office is situated at Technologiepark 21, 9052 Zwijnaarde, Belgium.

Smart Trust 345 – October 17, 2017 (October 17th, 2017)

The Bank of New York Mellon is acting as trustee for the series of Smart Trust set forth above (the "Trust"). We enclosed a list of the Securities to be deposited in the Trust on the date hereof. The prices indicated therein reflect our evaluation of such Securities as of close of business on October 16, 2017, in accordance with the valuation method set forth in the Standard Terms and Conditions of Trust and Trust Agreement. We consent to the reference to The Bank of New York Mellon as the party performing the evaluations of the Trust Securities in the Registration Statement (No. 333-219812) filed with the Securities and Exchange Commission with respect to the registration of the sale of the Trust Units and to the filing of this consent as an exhibit thereto.

Adgero Biopharmaceuticals Holdings, Inc. – Employment Agreement (October 17th, 2017)

This EMPLOYMENT AGREEMENT (this "Agreement"), dated as of September 1, 2017 is by and between ADGERO BIOPHARMACEUTICALS HOLDINGS, INC., a Delaware corporation (the "Company") and Felix Garzon (the "Employee").

VALEANT PHARMACEUTICALS INTERNATIONAL, INC. $1,000,000,000 5.500% SENIOR SECURED NOTES DUE 2025 INDENTURE DATED AS OF October 17, 2017 THE BANK OF NEW YORK MELLON, AS TRUSTEE AND THE NOTES COLLATERAL AGENTS PARTY HERETO (October 17th, 2017)

THIS INDENTURE dated as of October 17, 2017 is among Valeant Pharmaceuticals International, Inc., a corporation continued under the British Columbia Business Corporations Act (the Company), the Note Guarantors party hereto, The Bank of New York Mellon (BNY Mellon), a New York banking corporation, not in its individual capacity but solely as Trustee, Registrar, and Paying Agent (the Trustee), BNY Mellon, as a notes collateral agent (together with certain of its branches, affiliates and agents party hereto) and Lord Securities Corporation (LSC), a corporation organized under the laws of the State of Delaware, as a notes collateral agent.

Master Services Agreement (October 17th, 2017)

THIS MASTER SERVICE AGREEMENT is entered into as of October 16, 2017 among BROOKFIELD ASSET MANAGEMENT INC., a corporation existing under the laws of the Province of Ontario ("Brookfield"), BRP ENERGY GROUP L.P., a limited partnership existing under the laws of the Province of Manitoba ("Canadian Service Provider"), BROOKFIELD ASSET MANAGEMENT PRIVATE INSTITUTIONAL CAPITAL ADVISER (CANADA), L.P., a limited partnership existing under the laws of the Province of Manitoba ("Canadian Service Provider II"), BROOKFIELD GLOBAL RENEWABLE ENERGY ADVISOR LIMITED, a company existing under the laws of England ("UK Service Provider"), TERRAFORM POWER, INC., a Delaware corporation ("TERP"), TERRAFORM POWER, LLC, a Delaware limited liability company ("TERP LLC"), and TERRAFORM POWER OPERATING, LLC, a Delaware limited liability company ("TERP Operating").

BUSINESS COMBINATION AGREEMENT Dated as of October 17, 2017 by and Among IMPAX LABORATORIES, INC., ATLAS HOLDINGS, INC., K2 MERGER SUB CORPORATION and AMNEAL PHARMACEUTICALS LLC (October 17th, 2017)

This THIRD AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT (this Agreement), dated as of [ ], is entered into by and among Amneal Pharmaceuticals LLC, a Delaware limited liability company (the Company), and its Members (as defined herein).

Adgero Biopharmaceuticals Holdings, Inc. – Employment Agreement (October 17th, 2017)

This EMPLOYMENT AGREEMENT (this "Agreement"), dated as of October 11, 2017 is by and between ADGERO BIOPHARMACEUTICALS HOLDINGS, INC., a Delaware corporation (the "Company") and John Liatos (the "Employee").

SCIENTIFIC GAMES INTERNATIONAL, INC. As Issuer and DEUTSCHE BANK TRUST COMPANY AMERICAS as Trustee and Collateral Agent and THE GUARANTORS PARTY HERETO 5.000% Senior Secured Notes Due 2025 (October 17th, 2017)

INDENTURE, dated as of October 17, 2017, among Scientific Games International, Inc., a Delaware corporation (the Issuer), the Guarantors (as defined herein) party hereto and Deutsche Bank Trust Company Americas, a New York banking corporation, as Trustee (the Trustee) and collateral agent.

Janel World Trade – LOAN AND SECURITY AGREEMENT Dated as of October 17, 2017 Between SANTANDER BANK, N.A., as Lender, JANEL GROUP, INC., PCL TRANSPORT, LLC, JANEL ALPHA GP, LLC, W.J. BYRNES & CO., INC., LIBERTY INTERNATIONAL, INC., THE JANEL GROUP OF GEORGIA, INC. Jointly and Severally, Individually and Collectively, as Borrower, and JANEL CORPORATION, as a Loan Party Obligor (October 17th, 2017)

This Loan and Security Agreement (as it may be amended, restated or otherwise modified from time to time, this "Agreement") is entered into as of October 17, 2017, among (1) SANTANDER BANK, N.A., a national banking association ("Lender"), (2) JANEL GROUP, INC., a New York corporation ("Janel"), PCL TRANSPORT, LLC, a New Jersey limited liability company ("PCL"), JANEL ALPHA GP, LLC, a Delaware limited liability company ("Alpha"), W.J. BYRNES & CO., INC., a California corporation ("Byrnes"), LIBERTY INTERNATIONAL, INC., a Rhode Island corporation ("Liberty"), THE JANEL GROUP OF GEORGIA, INC., a Georgia corporation ("Georgia", and together with Janel, PCL, Alpha, Byrnes, and Liberty, individually and collectively, and jointly and severally referred to herein as "Borrower"), and (3) JANEL CORPORATION, a Nevada corporation ("Parent"), as a Loan Party Obligor (as defined herein). The Schedules and Exhibits to this Agreement are an integral part of this Agreement and are incorporated herein b

Smart Trust 344 – October 17, 2017 (October 17th, 2017)

The Bank of New York Mellon is acting as trustee for the series of Smart Trust set forth above (the "Trust"). We enclosed a list of the Securities to be deposited in the Trust on the date hereof. The prices indicated therein reflect our evaluation of such Securities as of close of business on October 16, 2017, in accordance with the valuation method set forth in the Standard Terms and Conditions of Trust and Trust Agreement. We consent to the reference to The Bank of New York Mellon as the party performing the evaluations of the Trust Securities in the Registration Statement (No. 333-219811) filed with the Securities and Exchange Commission with respect to the registration of the sale of the Trust Units and to the filing of this consent as an exhibit thereto.

Janel World Trade – Revolving Credit Note (October 17th, 2017)

This Note is one of the Revolving Credit Notes referred to in, and issued pursuant to, that certain Loan and Security Agreement dated as of October 17, 2017, by and between Borrower and Lender (as hereinafter amended from time to time, the "Loan and Security Agreement"), and is entitled to all of the benefits and security of the Loan and Security Agreement. All capitalized terms used herein, unless otherwise specifically defined in this Note, shall have the meanings ascribed to them in the Loan and Security Agreement.

Ablynx NV – RESEARCH COLLABORATION AND EXCLUSIVE LICENSE AGREEMENT by and Between MERCK SHARP & DOHME CORP. And ABLYNX N.V. (October 17th, 2017)

THIS RESEARCH COLLABORATION AND EXCLUSIVE LICENSE AGREEMENT (this Agreement), effective as of January 31, 2014 (the Effective Date), is made by and between MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey (Merck) and ABLYNX N.V., a limited liability company organized and existing under the laws of Belgium (Ablynx) registered with the legal entities register under number BE 0475295446 (district of Ghent) and whose registered office is situated at Technologiepark 21, 9052 Zwijnaarde, Belgium.

Akers Biosciences Inc – Warrant Exercise Agreement (October 13th, 2017)

This Warrant Exercise Agreement (this "Agreement"), dated as of October 12, 2017, is by and between Akers Biosciences, Inc., a New Jersey corporation (the "Company"), and the undersigned holder (the "Holder") of warrants to purchase shares of the Company's common stock, no par value (the "Common Stock").

Ablynx NV – COLLABORATION AND LICENSE AGREEMENT Between ABLYNX N.V. And SANOFI (October 13th, 2017)

This Collaboration and License Agreement (this Agreement) is entered into as of July 19, 2017 (the Effective Date), by and between Ablynx N.V., a company incorporated under the laws of Belgium having an address at Technologiepark 21, 9052 Zwijnaarde, Belgium (Ablynx), and Sanofi, a societe anonyme duly organized and existing under the laws of France having an address at 54, rue de la Boetie, 75017 Paris, France (Sanofi). Ablynx and Sanofi may sometimes individually be referred to hereafter as a Party or, collectively, as the Parties.

Akers Biosciences Inc – Common Stock Purchase Warrant Akers Biosciences, Inc. (October 13th, 2017)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the six-month anniversary of the Issue Date (the "Initial Exercise Date") and on or prior to the close of business on the five-year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Akers Biosciences, Inc., a New Jersey corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

MANAGEMENT AND LEASE SUPPORT AGREEMENT (Non-Cplv) by and Among CEOC, LLC and the Entities Listed on Schedule B (Collectively, and Together With Their Respective Successors and Permitted Assigns) as Tenant Non-Cplv Manager, LLC (Together With Its Successors and Permitted Assigns) as Manager Caesars Entertainment Corporation (Together With Its Successors and Permitted Assigns) as Lease Guarantor the Entities Listed on Schedule a (Collectively, and Together With Their Respective Successors and Permitted Assigns) as Landlord And, Solely for Purposes of Article VII and Sections 2.4, 16.2, 16.3.4, 1 (October 13th, 2017)

This MANAGEMENT AND LEASE SUPPORT AGREEMENT (this Agreement) is dated as of October 6, 2017, and is made and entered into by and among CEOC, LLC, a Delaware limited liability company, and the entities listed on Schedule B attached hereto (collectively or, if the context clearly requires, individually, and together with their respective successors and permitted assigns, Tenant), Non-CPLV Manager, LLC, a Delaware limited liability company (together with its successors and permitted assigns, Manager), Caesars Entertainment Corporation, a Delaware corporation (together with its successors and permitted assigns, CEC, and sometimes alternatively referred to herein as Lease Guarantor), the entities listed on Schedule A attached hereto (collectively, and together with their respective successors and permitted assigns, Landlord), solely for purposes of Article VII and Sections 2.4, 16.2, 16.3.4, 18.5.5, 18.7.3, 18.7.4, 18.7.5, 19.3, 20.2 and 20.16, Caesars License Company, LLC, a Nevada limited

Separation Agreement (October 13th, 2017)

This SEPARATION AGREEMENT, dated as of October 6, 2017 (this Agreement), and effective as of the Effective Date (as such term is defined in the Bankruptcy Plan (defined below)), is by and between Caesars Entertainment Operating Company, Inc., a Delaware corporation (OpCo), and VICI Properties Inc., a Maryland corporation (REIT).

Marlin Business Services Corp. – Separation and General Release Agreement (October 13th, 2017)

This Separation and General Release Agreement (Agreement) is made by and between Edward J. Siciliano (you) and Marlin Business Services Corp. (the Company) and shall be effective as of the date on which you execute this Agreement as set forth below.

Ablynx NV – RESEARCH COLLABORATION AND EXCLUSIVE LICENSE AGREEMENT by and Between MERCK SHARP & DOHME CORP. And ABLYNX N.V. (October 13th, 2017)

THIS RESEARCH COLLABORATION AND EXCLUSIVE LICENSE AGREEMENT (this Agreement), effective as of January 31, 2014 (the Effective Date), is made by and between MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey (Merck) and ABLYNX N.V., a limited liability company organized and existing under the laws of Belgium (Ablynx) registered with the legal entities register under number BE 0475295446 (district of Ghent) and whose registered office is situated at Technologiepark 21, 9052 Zwijnaarde, Belgium.

LEASE (NON-CPLV) by and Among the Entities Listed on Schedule a (Collectively, and Together With Their Respective Permitted Successors and Assigns) as Landlord and CEOC, LLC and the Entities Listed on Schedule B (Collectively, and Together With Their Respective Permitted Successors and Assigns) as Tenant Dated October 6, 2017 for the Properties Listed on Exhibit A (October 13th, 2017)

THIS LEASE (NON-CPLV) (this Lease) is entered into as of October 6, 2017, by and among the entities listed on Schedule A attached hereto (collectively, and together with their respective successors and assigns, Landlord), and CEOC, LLC, a Delaware limited liability company, and the entities listed on Schedule B attached hereto (collectively, or if the context clearly requires, individually, and together with their respective successors and assigns, Tenant).

Lightlake Therapeutics Inc. – Contract (October 13th, 2017)

Confidential Treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as "****". A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.